000 | 01962 a2200541 4500 | ||
---|---|---|---|
005 | 20250516110937.0 | ||
264 | 0 | _c20130121 | |
008 | 201301s 0 0 eng d | ||
022 | _a1090-2430 | ||
024 | 7 |
_a10.1016/j.expneurol.2012.08.023 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZheng, H | |
245 | 0 | 0 |
_aMitotoxicity and bortezomib-induced chronic painful peripheral neuropathy. _h[electronic resource] |
260 |
_bExperimental neurology _cDec 2012 |
||
300 |
_a225-34 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetylcarnitine _xtherapeutic use |
650 | 0 | 4 |
_aActivating Transcription Factor 3 _xmetabolism |
650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xtoxicity |
650 | 0 | 4 |
_aAxons _xdrug effects |
650 | 0 | 4 |
_aBoronic Acids _xtoxicity |
650 | 0 | 4 | _aBortezomib |
650 | 0 | 4 |
_aCitrate (si)-Synthase _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aElectron Transport Complex II _xmetabolism |
650 | 0 | 4 |
_aGanglia, Spinal _xpathology |
650 | 0 | 4 |
_aHyperalgesia _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMitochondria _xdrug effects |
650 | 0 | 4 |
_aPain _xdrug therapy |
650 | 0 | 4 | _aPain Measurement |
650 | 0 | 4 |
_aPain Threshold _xdrug effects |
650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xchemically induced |
650 | 0 | 4 |
_aPyrazines _xtoxicity |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSchwann Cells _xpathology |
650 | 0 | 4 |
_aSciatic Nerve _xphysiopathology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aUbiquitin Thiolesterase _xmetabolism |
700 | 1 | _aXiao, W H | |
700 | 1 | _aBennett, G J | |
773 | 0 |
_tExperimental neurology _gvol. 238 _gno. 2 _gp. 225-34 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.expneurol.2012.08.023 _zAvailable from publisher's website |
999 |
_c22075766 _d22075766 |